Annual Secretarial Compliance Report for the financial year ending March 31, 2026
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Titan Biotech Ltd has filed its Annual Secretarial Compliance Report for FY 2025-26, as mandated under SEBI Regulation 24A. The report, issued by Practicing Company Secretary Amit Anand on April 24, 2026, confirms that the company maintained full compliance with all SEBI regulations throughout the review period. No deviations or violations were reported across all checked items including SEBI LODR, Takeover Regulations, Insider Trading Regulations, and secretarial standards. The auditor verified compliance with related party transactions, website disclosures, document preservation, and performance evaluation requirements. No actions were taken by SEBI or stock exchanges against the company, its promoters, or directors during the period. This clean report was submitted to BSE on May 4, 2026.
This clean compliance report indicates strong governance practices with no regulatory issues. Shareholders can view this positively as the company has maintained full adherence to SEBI requirements without any penalties or show cause notices.